Hawaii Minority-Based Clinical Community Oncology Program

夏威夷少数民族临床社区肿瘤学计划

• 批准号: 8484351
• 负责人: Jeffrey Lee Berenberg
• 金额: $ 73.68万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-08-01 至 2014-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8484351
• 关键词: Age; Allied Health Personnel; Belief; Cancer Burden; Cancer Control; Cancer Control Research; Cancer Patient; Cancer Prevention Trial; Cancer Research Center of Hawaii; Caucasians; Caucasoid Race; Clinical Oncology; Clinical Research; Clinical Trials; Communities; Community Participation; Conduct Clinical Trials; Consensus; Controlled Clinical Trials; Controlled Study; Data; Discipline of Nursing; Economics; Ethnic Origin; Ethnic group; Gastroenterologist; Gender; Goals; Guidelines; Gynecologic Oncology Group; Hawaii; Health Educators; Health Insurance Portability and Accountability Act; Health Personnel; Hospitals; Incidence; Indium; Individual; Institution; Island; Language; Malignant Neoplasms; Minority; Minority-Based Community Clinical Oncology Program; Morbidity - disease rate; NCI Center for Cancer Research; National Cancer Institute; National Comprehensive Cancer Network; National Surgical Adjuvant Breast and Bowel Project; Oncologist; Patients; Pharmacists; Physician Data Query; Physicians; Population; Prevention; Prevention strategy; Primary Health Care; Progress Reports; Provider; Publishing; Radiation Therapy Oncology Group; Recommendation; Research; Research Activity; Research Infrastructure; Research Personnel; Science; Social Medicine; Source; Southwest Oncology Group; Specialist; Surgical Specialties; Symptoms; Testing; Time; Underserved Population; United States; United States National Institutes of Health; base; cancer care; cancer prevention; cancer therapy; clinical practice; data management; design; ethnic minority population; high risk; improved; medical specialties; meetings; mortality; novel; outcome forecast; response; success; symposium; treatment effect

The primary objective of the Hawaii Minority-Based Community Clinical Oncology (MBCCOP) is to build on its past 15 year success in providing National Cancer Institute (NCI) clinical trials to Hawaii cancer patients and high risk individuals in order to reduce cancer incidence, morbidity and mortality by: 1. providing support to expand clinical research in the State of Hawaii, a multiethnic population with a majority of ethnic minority patients; 2. bringing the advantages of state-of-the-science treatment and prevention/control research to minority individuals in their own communities; 3. facilitating broader participation among underserved populations in NCI-approved research; 4. strengthening the operational base that presently exists to extend cancer prevention and control research in the population; 5. increasing the involvement of primary health care providers and other specialists in cancer treatment, prevention, and control studies. The Cancer Research Center of Hawaii will serve as the administrative headquarters for the MBCCOP and will direct recruitment, accrual, and data management for NCI-approved cancer treatment, prevention and symptom control clinical trials. Sources of clinical trials include: SWOG, GOG, COG, RTOG, URCC, CTSU, and NSABP prevention trials. Participating physicians include oncologists on Oahu, Kauai, Maui, and the Big Island of Hawaii as well as professionals from other medical and non-medical specialties. All major hospitals in the state will serve as component/affiliate institutions. The MBCCOP will allow the people of Hawaii, about 75% who are ethnic minorities, to benefit from access to state-of-the-science cancer treatment, prevention and symptom control studies while providing valuable clinical research data on a unique population.

夏威夷少数民族社区临床肿瘤学 (MBCCOP) 的主要目标是在过去 15 年成功为夏威夷癌症患者和高危人群提供国家癌症研究所 (NCI) 临床试验的基础上，通过以下方式降低癌症发病率、发病率和死亡率： 1. 为夏威夷州（一个以少数民族患者为主的多民族人口）扩大临床研究提供支持； 2. 将最先进的治疗和预防/控制研究的优势带给其所在社区的少数群体； 3. 促进服务不足的人群更广泛地参与 NCI 批准的研究； 4. 加强现有的业务基础，以在人群中推广癌症预防和控制研究； 5. 增加初级卫生保健提供者和其他专家对癌症治疗、预防和控制研究的参与。夏威夷癌症研究中心将作为 MBCCOP 的行政总部，负责指导 NCI 批准的癌症治疗、预防和症状控制临床试验的招募、应计和数据管理。临床试验的来源包括：SWOG、GOG、COG、RTOG、URCC、CTSU 和 NSABP 预防试验。参与的医生包括欧胡岛、考艾岛、毛伊岛和夏威夷大岛的肿瘤学家以及其他医学和非医学专业的专业人员。该州所有主要医院都将作为组成/附属机构。 MBCCOP 将使夏威夷人民（约 75% 为少数民族）受益于最先进的癌症治疗、预防和症状控制研究，同时提供有关独特人群的宝贵临床研究数据。